Mark W.M. Schellings

Author

Also Known As

M SCHELLINGS, M Schellings, M W M Schellings, M. Schellings, M. W. M. Schellings, M.W.M. Schellings, Mark Schellings, Mark W M Schellings, Mark W Schellings, Mark W. M. Schellings

Publications

2.8K

Citations

H-Index

Concepts

All Affiliations

Maastricht University KU Leuven Benaroya Research Institute Máxima Medisch Centrum Amsterdam UMC Location University of Amsterdam

About

Mark W.M. Schellings is an author at Maastricht University specializing in medicine, cardiology, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	1.4K
2	Cell Biology	4	4	1.2K
3	Natural Sciences	1	1	243
4	Cellular Physiology	1	1	72
5	Immunology	1	1	52

Mark W.M. Schellings

Publications

2.4K

Citations

H-Index

Page 1

	Year	Citations
miR-133 and miR-30 Regulate Connective Tissue Growth Factor Rudy F. Duisters, Anke J. Tijsen, Blanche Schroen, Circulation Research CardiomyopathyDevelopmental BiologyCardiac ReprogrammingMajor Cardiac MicrornasGene Expression	2008	810
MicroRNA‐18 and microRNA‐19 regulate CTGF and TSP‐1 expression in age‐related heart failure Geert C. van Almen, Wouter Verhesen, Rick E.W. van Leeuwen, Aging Cell Heart FailureCardiac AgingAgingCardiovascular FunctionAge‐related Heart Failure	2011	243
Absence of SPARC results in increased cardiac rupture and dysfunction after acute myocardial infarction Mark W.M. Schellings, Davy Vanhoutte, Melissa Swinnen, The Journal of Experimental Medicine	2008	205
Determination of dabigatran, rivaroxaban and apixaban by ultra‐performance liquid chromatography – tandem mass spectrometry (UPLC‐MS/MS) and coagulation assays for therapy monitoring of novel direct oral anticoagulants E.M.H. Schmitz, Kjm Kristel Boonen, D.J.A. van den Heuvel, Journal of Thrombosis and Haemostasis ThrombosisTherapeutic Drug MonitoringTherapy MonitoringCoagulation AssaysHematology	2014	169
The Extent of Coronary Atherosclerosis Is Associated With Increasing Circulating Levels of High Sensitive Cardiac Troponin T Eduard M. Laufer, Alma M.A. Mingels, Mark H.M. Winkens, Arteriosclerosis Thrombosis and Vascular Biology	2010	144
Hypoxia Induces Aortic Hypertrophic Growth, Left Ventricular Dysfunction, and Sympathetic Hyperinnervation of Peripheral Arteries in the Chick Embryo Ellen V. Rouwet, Andrei N. Tintu, Mark W.M. Schellings, Circulation	2002	132
Increased Expression of Syndecan-1 Protects Against Cardiac Dilatation and Dysfunction After Myocardial Infarction Davy Vanhoutte, Mark W.M. Schellings, Martin Götte, Circulation	2007	126
Absence of Thrombospondin-2 Causes Age-Related Dilated Cardiomyopathy Melissa Swinnen, Davy Vanhoutte, Geert C. van Almen, Circulation	2009	103
Sema3A promotes the resolution of cardiac inflammation after myocardial infarction Marieke Rienks, Paolo Carai, Nicole Bitsch, Basic Research in Cardiology	2017	88
Syndecan-1 Amplifies Angiotensin II–Induced Cardiac Fibrosis Mark W.M. Schellings, Davy Vanhoutte, Geert C. van Almen, Hypertension Cardiovascular PharmacologyCellular PhysiologyInflammationAngiogenesisCollagen Type	2010	72

Page 1